U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) Director Peter Francis Minan purchased 492 shares of U.S. Physical Therapy stock in a transaction dated Monday, June 8th. The stock was bought at an average cost of $63.14 per share, with a total value of $31,064.88. Following the completion of the transaction, the director owned 2,923 shares in the company, valued at approximately $184,558.22. This represents a 20.24% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website.
Peter Francis Minan also recently made the following trade(s):
- On Tuesday, June 9th, Peter Francis Minan purchased 288 shares of U.S. Physical Therapy stock. The shares were purchased at an average cost of $61.50 per share, with a total value of $17,712.00.
U.S. Physical Therapy Stock Performance
USPH stock opened at $65.66 on Friday. The firm has a market cap of $999.35 million, a price-to-earnings ratio of 131.32, a PEG ratio of 1.82 and a beta of 1.16. The firm has a 50-day simple moving average of $68.21 and a two-hundred day simple moving average of $76.26. U.S. Physical Therapy, Inc. has a one year low of $58.19 and a one year high of $93.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.19 and a current ratio of 1.19.
U.S. Physical Therapy Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, June 12th. Shareholders of record on Friday, May 22nd were given a dividend of $0.46 per share. This represents a $1.84 annualized dividend and a dividend yield of 2.8%. The ex-dividend date of this dividend was Friday, May 22nd. U.S. Physical Therapy’s dividend payout ratio is presently 368.00%.
Analysts Set New Price Targets
USPH has been the subject of several analyst reports. Citigroup reissued an “outperform” rating on shares of U.S. Physical Therapy in a research report on Friday, May 8th. Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of U.S. Physical Therapy in a research report on Friday, May 29th. Citizens Jmp reduced their target price on U.S. Physical Therapy from $113.00 to $98.00 and set a “market outperform” rating on the stock in a research report on Friday, May 8th. Finally, Barrington Research reduced their target price on U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 13th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, U.S. Physical Therapy has an average rating of “Moderate Buy” and a consensus price target of $97.50.
Get Our Latest Stock Analysis on U.S. Physical Therapy
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in USPH. Royal Bank of Canada increased its position in U.S. Physical Therapy by 3.4% during the 1st quarter. Royal Bank of Canada now owns 79,238 shares of the company’s stock valued at $5,733,000 after buying an additional 2,594 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in U.S. Physical Therapy by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,897 shares of the company’s stock valued at $644,000 after buying an additional 391 shares in the last quarter. Jane Street Group LLC increased its position in U.S. Physical Therapy by 249.3% during the 1st quarter. Jane Street Group LLC now owns 49,309 shares of the company’s stock valued at $3,568,000 after buying an additional 35,191 shares in the last quarter. Hsbc Holdings PLC acquired a new position in U.S. Physical Therapy during the 2nd quarter valued at about $410,000. Finally, First Trust Advisors LP grew its stake in U.S. Physical Therapy by 3.7% during the 2nd quarter. First Trust Advisors LP now owns 10,725 shares of the company’s stock valued at $839,000 after purchasing an additional 385 shares during the last quarter.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
See Also
- Five stocks we like better than U.S. Physical Therapy
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
